Page last updated: 2024-08-23

bezafibrate and Myocardial Ischemia

bezafibrate has been researched along with Myocardial Ischemia in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (33.33)	18.2507
2000's	4 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anand, IS; Chodorowski, Z; Kaletha, K; Nagel-Starczynowska, G; Rybakowska, I	1
Mal', GS	1
Elisaf, MS; Mikhailidis, DP; Milionis, HJ	1
Kesäniemi, YA	1
Beggs, PW; Clark, DW; Coulter, DM; Williams, SM	1
Goldbourt, U; Graff, E; Koren-Morag, N; Tanne, D	1

Reviews

3 review(s) available for bezafibrate and Myocardial Ischemia

Article	Year
[Lipoproteins HDL and coronary artery disease: a molecular mechanism of fibrate]. Przeglad lekarski, 2003, Volume: 60, Issue:4 Topics: Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Hepatocytes; Humans; Hyperlipidemias; Hypolipidemic Agents; Myocardial Ischemia; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Up-Regulation	2003
Treatment of dyslipidaemias in patients with established vascular disease: a revival of the fibrates. Current medical research and opinion, 2000, Volume: 16, Issue:1 Topics: Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Myocardial Ischemia; Randomized Controlled Trials as Topic; Triglycerides	2000
Serum triglycerides and clinical benefit in lipid-lowering trials. The American journal of cardiology, 1998, Feb-26, Volume: 81, Issue:4A Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol, LDL; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Estrogen Replacement Therapy; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Myocardial Infarction; Myocardial Ischemia; Postmenopause; Pravastatin; Risk Factors; Simvastatin; Triglycerides	1998

Trials

1 trial(s) available for bezafibrate and Myocardial Ischemia

Article	Year
[Comparative efficiency of prolonged diet and drug therapies for hyperlipidemias in patients with ischemic heart disease]. Klinicheskaia meditsina, 2004, Volume: 82, Issue:5 Topics: Aged; Bezafibrate; Cholesterol, LDL; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Myocardial Ischemia; Niacin; Time Factors	2004

Other Studies

2 other study(ies) available for bezafibrate and Myocardial Ischemia

Article	Year
A comparison of the use, effectiveness and safety of bezafibrate, gemfibrozil and simvastatin in normal clinical practice using the New Zealand Intensive Medicines Monitoring Programme (IMMP). British journal of clinical pharmacology, 1999, Volume: 47, Issue:1 Topics: Bezafibrate; Cohort Studies; Comorbidity; Diabetes Complications; Female; Gemfibrozil; Humans; Hypertension; Lipids; Male; Myocardial Ischemia; New Zealand; Practice Patterns, Physicians'; Product Surveillance, Postmarketing; Random Allocation; Retrospective Studies; Risk Factors; Simvastatin; Surveys and Questionnaires; Treatment Outcome	1999
Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor. Circulation, 2001, Dec-11, Volume: 104, Issue:24 Topics: Age Factors; Aged; Bezafibrate; Cerebrovascular Disorders; Coronary Disease; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Ischemic Attack, Transient; Lipids; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Randomized Controlled Trials as Topic; Registries; Risk Factors; Triglycerides	2001

Article

Year

A comparison of the use, effectiveness and safety of bezafibrate, gemfibrozil and simvastatin in normal clinical practice using the New Zealand Intensive Medicines Monitoring Programme (IMMP).

British journal of clinical pharmacology, 1999, Volume: 47, Issue:1

Topics: Bezafibrate; Cohort Studies; Comorbidity; Diabetes Complications; Female; Gemfibrozil; Humans; Hypertension; Lipids; Male; Myocardial Ischemia; New Zealand; Practice Patterns, Physicians'; Product Surveillance, Postmarketing; Random Allocation; Retrospective Studies; Risk Factors; Simvastatin; Surveys and Questionnaires; Treatment Outcome

1999

Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor.

Circulation, 2001, Dec-11, Volume: 104, Issue:24

Topics: Age Factors; Aged; Bezafibrate; Cerebrovascular Disorders; Coronary Disease; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Ischemic Attack, Transient; Lipids; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Randomized Controlled Trials as Topic; Registries; Risk Factors; Triglycerides

2001